Predict your next investment

FINANCIAL | Insurance / Health Insurance
insuringsmiles.com

See what CB Insights has to offer

Stage

Acquired | Acquired

Total Raised

$20.75M

About Health Resources

Dental Health Options by Health Resources is a dental benefit provider for employer group in Indiana and Kentucky.

Health Resources Headquarter Location

5010 Carriage Drive

Evansville, Indiana, 47715,

United States

812-424-1444

Latest Health Resources News

HRSA intends to fine 6 drugmakers over 340B contract pharmacy violations

Sep 23, 2021

Sep 23, 2021 7:00am The Health Resources and Services Administration has referred six drugmakers to get monetary penalties after ignoring a request to resume sales to 340B contract pharmacies. (Getty/Tero Vesalainen) The Biden administration is moving to fine six drug companies for refusing to offer drugs discounted under the 340B program to contract pharmacies, even as a federal lawsuit over the authority to penalize the drug companies continues. Wednesday, the Health Resources and Services Administration (HRSA) referred the six drugmakers to the Department of Health and Human Services' Office of Inspector General for penalties for violating the 340B statute. Eli Lilly, Sanofi, AstraZeneca, Novartis, Novo Nordisk, and United Therapeutics all received letters dated Wednesday outlining the update. The six drugmakers were warned back in May by the HRSA that moves to restrict sales to contract pharmacies violated the 340B statute. The drugmakers could face more than $5,000 a violation if the fines are assessed. But it remains unclear whether the penalties will be enforced. Eli Lilly sued the Biden administration in federal court back in May shortly after the warnings. The goal of the lawsuit was to prevent the federal government from penalizing drug companies for restricting sales to contract pharmacies. HRSA’s decision was cheered by 340B advocates who say safety net providers have been harmed by the drugmakers’ actions, which started last summer. “Despite unequivocal determinations from the government that these drugmaker actions are unlawful, the companies continue to ignore federal law and refuse to offer 340B pricing on drugs dispensed at community pharmacies,” said Maureen Testoni, president and CEO of advocacy group 340B Health. “The longer these drugmakers refuse to follow the law, to stop overcharging for 340B drugs, and to repay the denied savings, the greater the harm will be to patient care.” Sanofi responded that its integrity initiative is intended to combat duplicative discounts for both Medicaid and 340B and that the initiative complies with the statute. The other five drugmakers did not immediately respond to a request for comment. Drugmakers agree to give 340B discounts to safety net providers in exchange for participation in Medicare and Medicaid. But drug manufacturers have complained that the program has gotten too large and question whether the benefits of the discounts reach patients. Hospitals and 340B advocates counter the program is vital to help safety net providers that operate on thin margins and as drugmakers have continued to raise prices. Read more on

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Research containing Health Resources

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Health Resources in 1 CB Insights research brief, most recently on May 26, 2021.

Expert Collections containing Health Resources

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Health Resources is included in 2 Expert Collections, including Health Plans & Benefits Management.

H

Health Plans & Benefits Management

693 items

Companies developing or offering digital platforms and services, including online insurance marketplaces, data analytics for claims adjustment, benefits administration, and payments systems, that help make private health insurance more affordable, navigable, or transparent.

D

Dental Health

957 items

Companies delivering dental care products and services. Excludes practice networks.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.